Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-17 22:13 | 2020-06-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $162.92 | 212,337 | $34,593,137 | 111,985,304 | -0.2% |
| 2020-06-09 23:52 | 2020-06-05 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $150.00 | 10,000 | $1,500,000 | 46,646 | -17.7% |
| 2020-04-28 19:21 | 2020-04-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $163.60 | 12,663 | $2,071,715 | 112,197,641 | 0.0% |
| 2020-04-27 21:36 | 2020-04-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $162.47 | 220,000 | $35,743,224 | 112,210,304 | -0.2% |
| 2020-04-27 17:39 | 2020-04-23 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $160.12 | 230,000 | $36,826,588 | 112,430,304 | -0.2% |
| 2020-04-16 18:23 | 2020-04-14 | LLY | ELI LILLY & Co | Shah Aarti S. | Officer; SVP & CIO | Pharmaceutical Preparations | SALE | $150.00 | 2,000 | $300,000 | 19,087 | -9.5% |
| 2020-04-13 21:43 | 2020-04-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $145.42 | 230,000 | $33,445,542 | 112,660,304 | -0.2% |
| 2020-04-08 19:49 | 2020-04-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $143.20 | 172,315 | $24,676,283 | 112,890,304 | -0.2% |
| 2020-04-07 18:40 | 2020-04-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $142.73 | 15,962 | $2,278,322 | 113,062,619 | 0.0% |
| 2020-04-06 21:42 | 2020-04-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $143.19 | 26,723 | $3,826,493 | 113,078,581 | 0.0% |
| 2020-04-03 19:42 | 2020-04-02 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $140.78 | 166,038 | $23,374,647 | 113,105,304 | -0.1% |
| 2020-04-01 20:47 | 2020-03-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $140.07 | 38,962 | $5,457,474 | 113,271,342 | 0.0% |
| 2020-03-31 23:03 | 2020-03-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $139.11 | 210,000 | $29,213,562 | 113,310,304 | -0.2% |
| 2020-03-31 18:50 | 2020-03-30 | LLY | ELI LILLY & Co | Fry Stephen F | Officer; SVP, HR & Diversity | Pharmaceutical Preparations | SALE | $134.30 | 14,657 | $1,968,435 | 107,415 | -12.0% |
| 2020-03-18 17:44 | 2020-03-16 | LLY | ELI LILLY & Co | Norton Johna | Officer; Senior VP, Global Quality | Pharmaceutical Preparations | SALE | $131.00 | 4,727 | $619,237 | 17,674 | -21.1% |
| 2020-03-06 18:46 | 2020-03-04 | LLY | ELI LILLY & Co | O'Neill Myles | Officer; SVP & Pres., Mfg. Operations | Pharmaceutical Preparations | SALE | $140.15 | 25,000 | $3,503,750 | 8,469 | -74.7% |
| 2020-03-03 23:27 | 2020-03-02 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; Chief Accounting Officer | Pharmaceutical Preparations | SALE | $128.00 | 3,700 | $473,600 | 4,740 | -43.8% |
| 2020-02-06 22:27 | 2020-02-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $146.61 | 200,000 | $29,321,800 | 113,520,304 | -0.2% |
| 2020-01-14 21:37 | 2020-01-13 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $138.92 | 205,000 | $28,478,498 | 113,720,304 | -0.2% |
| 2020-01-13 19:00 | 2020-01-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $138.00 | 210,000 | $28,979,013 | 113,925,304 | -0.2% |
| 2020-01-10 21:45 | 2020-01-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $135.79 | 220,000 | $29,874,724 | 114,135,304 | -0.2% |
| 2020-01-09 22:04 | 2020-01-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $133.32 | 172,650 | $23,018,112 | 114,355,304 | -0.2% |
| 2020-01-08 19:33 | 2020-01-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $132.90 | 32,645 | $4,338,579 | 114,527,954 | 0.0% |
| 2019-12-23 17:48 | 2019-12-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $132.90 | 19,705 | $2,618,812 | 114,560,599 | 0.0% |
| 2019-12-19 22:36 | 2019-12-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $129.29 | 220,000 | $28,443,844 | 114,580,304 | -0.2% |
| 2019-12-18 19:31 | 2019-12-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $125.69 | 215,000 | $27,023,544 | 114,800,304 | -0.2% |
| 2019-12-10 19:49 | 2019-12-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $119.70 | 10,962 | $1,312,151 | 115,015,304 | 0.0% |
| 2019-12-10 19:56 | 2019-12-06 | LLY | ELI LILLY & Co | O'Neill Myles | Officer; SVP & Pres., Mfg. Operations | Pharmaceutical Preparations | SALE | $120.00 | 25,000 | $3,000,000 | 33,414 | -42.8% |
| 2019-12-09 17:51 | 2019-12-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $120.15 | 194,038 | $23,313,491 | 115,026,266 | -0.2% |
| 2019-12-10 00:37 | 2019-12-06 | LLY | ELI LILLY & Co | Zulueta Alfonso G | Officer; SVP & President, Lilly Int'l | Pharmaceutical Preparations | SALE | $120.00 | 4,500 | $540,000 | 29,306 | -13.3% |
| 2019-12-05 21:31 | 2019-12-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $118.52 | 210,000 | $24,890,040 | 115,220,304 | -0.2% |
| 2019-12-02 21:40 | 2019-11-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $117.51 | 48,953 | $5,752,257 | 115,430,304 | 0.0% |
| 2019-11-27 18:40 | 2019-11-26 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $117.81 | 56,729 | $6,683,470 | 115,479,257 | 0.0% |
| 2019-11-26 19:19 | 2019-11-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $117.60 | 109,318 | $12,855,797 | 115,535,986 | -0.1% |
| 2019-11-26 00:29 | 2019-11-22 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $116.25 | 251,736 | $29,263,605 | 115,645,304 | -0.2% |
| 2019-11-22 18:56 | 2019-11-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $115.14 | 108,264 | $12,465,506 | 115,897,040 | -0.1% |
| 2019-11-20 18:17 | 2019-11-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $115.06 | 205,000 | $23,586,767 | 116,005,304 | -0.2% |
| 2019-11-19 20:00 | 2019-11-18 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $114.00 | 10,598 | $1,208,172 | 116,210,304 | 0.0% |
| 2019-11-13 21:53 | 2019-11-12 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $114.00 | 7,981 | $909,841 | 116,220,902 | 0.0% |
| 2019-11-12 21:12 | 2019-11-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $114.07 | 100 | $11,407 | 116,228,883 | 0.0% |
| 2019-11-08 18:35 | 2019-11-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $114.37 | 400 | $45,749 | 116,228,983 | 0.0% |
| 2019-11-07 19:03 | 2019-11-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $114.05 | 173,918 | $19,835,000 | 116,229,383 | -0.1% |
| 2019-11-05 21:18 | 2019-11-04 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $114.04 | 7,003 | $798,608 | 116,403,301 | 0.0% |
| 2019-11-01 17:37 | 2019-10-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $114.00 | 190,000 | $21,659,639 | 116,410,304 | -0.2% |
| 2019-10-28 22:11 | 2019-10-25 | LLY | ELI LILLY & Co | White Anne E. | Officer; SVP & Pres-Lilly Oncology | Pharmaceutical Preparations | BUY | $108.84 | 1,000 | $108,840 | 22,043 | +4.8% |
| 2019-10-28 22:00 | 2019-10-25 | LLY | ELI LILLY & Co | Skovronsky Daniel | Officer; SVP, CSO, and Pres. LRL | Pharmaceutical Preparations | BUY | $108.61 | 5,000 | $543,050 | 75,818 | +7.1% |
| 2019-10-28 22:06 | 2019-10-25 | LLY | ELI LILLY & Co | Smiley Joshua L | Officer; SVP and CFO | Pharmaceutical Preparations | BUY | $107.59 | 929 | $99,951 | 31,524 | +3.0% |
| 2019-10-25 19:13 | 2019-10-25 | LLY | ELI LILLY & Co | Ricks David A | Director, Officer; President & CEO | Pharmaceutical Preparations | BUY | $108.38 | 4,615 | $500,174 | 157,405 | +3.0% |
| 2019-10-25 19:10 | 2019-10-24 | LLY | ELI LILLY & Co | TAI JACKSON P | Director | Pharmaceutical Preparations | BUY | $107.49 | 1,861 | $200,039 | 56,440 | +3.4% |
| 2019-09-23 20:33 | 2019-09-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $116.37 | 210,000 | $24,437,721 | 116,600,304 | -0.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.